Digital Health Meetings

Digital Health solutions are top of mind for biopharma companies in 2022, and Software as Medical Device (SaMD) is a crucial cornerstone for top-tier companies. Join this Masterclass led by BrightInsight to dive deeper into this topic and discuss this further with your peers working in this space.

Are you a DTx or Pharma company seeking wide-spread reimbursement of a DTx product in the US? Join this Masterclass led by Mike Pace to learn more about this topic and share your experiences with others working in this space.

With the pandemic, we saw a rapid expansion of telemedicine and remote patient monitoring (RPM) solutions as a new way of delivering healthcare. Join HealthXL in this meeting to discuss this topic further with others working in this space.

The investment case for digital health and oncology is straightforward - apply digital innovation to one of the most prevalent diseases worldwide, improve millions of patients' lives, and reap the rewards. Join your peers in this meeting to dive deeper into this topic.

Standalone digital therapeutics (DTx) solutions are not comparable to drugs or standard treatment protocols. Join this meeting to dive deeper into this topic with others working in this space.

How to successfully take a DTx product through the regulatory pathways in the US? Join this Masterclass led by Jason Brooke, medical device attorney and regulatory/quality advisor, as we dive deeper into this topic.

Join our next HealthXL Webinar with Cristina Duran, Chief Digital Health Officer R&D at AstraZeneca, as we discuss Digital Health in Oncology. Register now to secure your place!

Spotify, Disney, Amazon, what do all of these organizations have in common? Top class customer experience. Join this Masterclass led by Sutherland to learn more about successful customer experience strategies and how pharma and medtech companies can improve their customers' experience.

What is the partnership roadmap for pharma and digital therapeutics (DTx) companies collaborations? Join your peers working in this space to learn more about this topic and share your experiences.

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

‍

‍

How can we leverage technological advancements to drive an explosive evolution in pathology? Join this Masterclass led by Bill Taranto to dive deeper into this topic.

As the Digital Therapeutics (DTx) industry matures, regulation is becoming increasingly important. Join this meeting to share your experiences with others working in this space.

How can we design trials for our digital health tools so they are rigorously validated and regulated? Join this Masterclass led my Akili Interactive to learn more about this topic.

Within digital therapeutics (DTx), mental health is an area showing major potential, particularly given that drug compliance tends to be a considerable problem and pharmacological treatments are usually not enough to get the desired outcomes. Join this meeting to dive deeper into this topic and share your experiences with others in the field.

A company might be able to create excellent virtual care solutions, but it won't have much of an impact if no one uses them. Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

The marriage of digital health and oncology is very new, with companies still figuring out the best approach to establish in the market. Join this meeting to discuss this topic further with others working in this field.

Regulatory clearance and the best commercialization model for a digital health product are among the key components for success in a rapidly growing sector. Join this Masterclass led by Flying Health to dive deeper into this topic.

Millions of people worldwide suffer from immune-mediated, inflammatory conditions (IMIDs) such as rheumatoid arthritis, atopic dermatitis, psoriasis, ulcerative Colitis, and multiple sclerosis, to name a few. Join this meeting to discuss this and share your experiences with others working in this space.

As the Covid-19 pandemic shifted how people interact with healthcare, the relationship between pharma and patients changed as many moved away from conventional clinical settings. Join this meeting to discuss this topic further and share your thoughts and experiences with your peers.

Are you a Digital Health company, Pharma executive, Medtech executive, or Venture Capitalist (VC), working in Patient Support Programs (PSPs) in oncology and seeking guidance to build successful partnerships? Then keep reading, this meeting is for you

Real-world data (RWD) can be highly valuable to pharma companies; with several use cases from drug discovery and development to drug market access, label extensions, and understanding how their drugs and competitors are used in real life. Join this meeting to discuss this topic further with others working in this space.

While the relationship between digital therapeutics (DTx) and pharma is still in its infancy, we are seeing the emergence of some compelling models and partnerships that illustrate the opportunities in the market. Join HealthXL in this meeting to dive deeper into this topic.

As the digital health industry grows exponentially, patients and providers are being flooded by hundreds of digital health products. Join this meeting to share your experiences and learn from others working in this space.

Are you struggling with trial design for your digital health products? Join this meeting to discuss this further with others working in this space.

Are you trying to get your SaMD product regulated in the European Union (EU)? Join HelathXL in this meeting to discuss this topic further with others working in this space.

Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Novel digital biomarkers have the potential to be part of clinical trials, but there are still a lot of questions regarding their reliability and validation process. Join this meeting to discuss this topic further with your peers in the field.

Are you struggling with getting HCPs and patients to adopt your digital health solution in oncology? Apply now to join this series of two meetings to discuss this topic further and learn from your peers.

Join our upcoming webinar with Robert Garber from 7wireVentures as we discuss how to get funding for a digital health solution.

Are you a DTx or Pharma company seeking coverage of your DTx in the US market? How should we be thinking about value-based agreements (VBA) in the context of DTx reimbursement in the US? Join this masterclass led by biopharma and PDT outcomes-based contracting pioneer, Mike Pace, to dive deeper into this topic.

DTx-drug combinations (‘combo’) are becoming one of the easiest ways for digital therapeutics (DTx) companies to commercialize their products through pharma. Join this meeting to discuss this topic with others working in the Digital Therapeutics space.

Most digital therapeutics (DTx) companies opt to pursue B2B business models, such as partnerships with pharma, employers or payers. Join this meeting to discuss this further with other members working in this space.

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join this interactive masterclass led by Dr Victor Stephani to dive deeper into this topic and discuss the matter further with your peers in this field.

What are the best payment models for delivering virtual care to cardiovascular patients? How can we maximize adoption? Join this two-part meeting to share and learn from the experiences of others working in this field.

In theory, Digital Therapeutics (DTx) and pharma are natural bedfellows, with both looking for commercially viable ways to connect with patients and improve outcomes. Join HealthXL in this meeting to dive deeper into this topic.

Are you a DTx or Pharma company seeking to successfully navigate both fully-insured and self-insured health plan segments to get your DTx products reimbursed in the US? Join this interactive masterclass led by biopharma and DTx reimbursement expert Mike Pace to learn more about this topic and share your experience with the group.

Digital health vendors often seek payer collaborations, and solid clinical evidence is often needed to support this pathway. Join this interactive masterclass led by Jordan Silberman (Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.) to engage with your others in this field and discuss this matter further.

Most neurological conditions are complex diseases with no disease-modifying therapies. Join HealthXL in this meeting to discuss this further.

A company might be able to create excellent digital therapeutics (DTx), but it won't have much of an impact if no one uses them. Join your peers in this meeting to discuss how to approach the problem and how some have already solved it. 

Regulation is an absolute essential for companies who want to get their SaMD accepted into clinical and payer groups. Join this US-focused Masterclass led by Jason Brooke, medical device attorney and regulatory/quality advisor, to discuss the do’s and don’ts when attempting to take your SaMD through regulatory pathways in the US.

Are you working on bringing Digital Health solutions to oncology patients? What are the best routes to market to get paid? Apply now to join this session to discuss this topic further with your peers in this field.

Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!  

What are the do’s and don’ts when approaching employers for DTx reimbursement? Join your peers working in the space to discuss this topic further.

Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Are you a DTx start-up seeking capital to get your business going? Are you an investor in DTx products? Join this meeting to discuss this topic with your peers in this area.

What is the most efficient way for DTx companies to generate evidence? Join this meeting to dive deeper into this topic with your peers in the Digital Therapeutics community.

Join this webinar led YourCoach Health - Marina Borukhovich (CEO & founder) & Eugene Borukhovich (COO & co-founder) as they discuss health coaching in digital health offerings. Apply now to secure your place.

‍

Over the past decade, DTx products have shown significant benefits in the management of mental health patients. Join this meeting to discuss why pharma should take DTx solutions in mental health as an opportunity to improve their offerings.

Are you struggling with trial design for your digital health products? Join this Masterclass led by Suzanne Clough (Chief Medical Officer, AmalgamRx) to discuss this topic further.

Are you working on incorporating digital measures into clinical trials? This is for you! Sign up now to join this meeting and discuss this topic further with your peers in this field.

Are you a Digital Health company, Pharma executive, Medtech executive, or Venture Capitalist (VC), working in mental health and seeking guidance to build successful partnerships? Seats are limited so apply now to meet 1-2-1 with potential partners in the field to discuss potential challenges when building successful collaborations.

Are you struggling with building the right evidence generation strategy for your DTx? Join this session to discuss this topic with your peers in the HealthXL Digital Therapeutics Community.

Join this discussion which will deep dive into the opportunities for Pharma in the Virtual Care space. If you are working in the area of Cardiometabolic Diseases - this is the meeting for you!

‍

While we have seen a significant growth in the number of DTx - Pharma partnerships in the last few years, implementing a sustainable successful business model between the two companies remains a challenge and we are still in the exploratory phase. Apply now to join this sprint to discuss the current state of DTx-Pharma partnerships and what the future of these look like.

Many oncology patients have to deal not only with the tumor, but also with multiple comorbidities, especially in types of cancer strongly related to lifestyle (e.g. lung cancer). Apply to join this meeting to discuss with other senior leaders how Digital Health solutions can be used to address the comorbidities along the journey of oncology patients. 

There are many DTx companies who are at the forefront of shifting care into the hands of empowered patients, reducing the healthcare system cost. However, the question remains: who pays for DTx? Join this Australia-focused masterclass led by Bronwyn LeGrice, CEO and Managing Director at ANDHealth to dive deeper into this topic.

Are you working in the neurology DTx space? Join this meeting to learn from other members in the HealthXL Neurology Community.

Why are Digital Health - Pharma partnerships so important in oncology? How can we build successful collaborations? Join this session to learn from leaders in the space and discuss how to create valuable Pharma-DH partnerships in oncology.

Are you on the search for the most sustainable business model for your DTx within the EU? Join this meeting to discuss this further with other members of the HealthXL community.

Join us for our latest Webinar with Thorsten Rall, Global Head Digital of Transformation & Innovation at Novartis, as we discuss 'The integration of digital health into the pharma business model'. Register now to secure your place.

What are the keys to successfully engage patients with non-Prescription DTx (non-PDTs) products? Apply now to join your peers in discussing this topic further.

Are you struggling with building your evidence generation strategy for Standalone DTx? Apply now to join this meeting to discuss the challenges and best practices with your peers in this field.

Are you a Digital Health company, Pharma executive, Medtech executive, or Venture Capitalist (VC), working in oncology and seeking guidance to build successful partnerships? Then keep reading, this meeting may be for you.

‍

There is a growing interest in using digital tools to empower Oncology patients to monitor, report and manage their symptoms as they emerge. Apply now to join the discussion on how Digital Health in Oncology is being implemented and adopted by HCPs and Patients.

Are you working on the evidence generation strategy of DTx products in Mental Health? Do you want to hear from others’ experiences? Apply now to join the discussion and share your own thoughts and experiences on this topic.

Join our Digital Health Meeting as we look at the best routes to market in the EU for APAC companies looking to expand. If this sounds like your organisation, apply now and connect with others in this space.

‍

Are you trying to get your SaMD product regulated in Europe? Join us in this Masterclass led by S3 Connected Health to learn all about the do’s and don’ts when attempting to take your SaMD product through regulatory pathways in Europe. Apply now to secure your place.

Are you working on digital health solutions for patients with Cognitive Disorders? Are you struggling to drive patient & HCP adoption and to find the right solution-problem fit? Join us for this discussion where we will discuss the main challenges around HCP and patient adoption of digital health solutions for Cognitive Disorders.

Are you a DTx or Pharma company seeking Payer Reimbursement of a DTx product in the US? Keep reading, this masterclass is for you. Join us for this masterclass led by Mike Pace, where we will focus on demystifying US Payer Access Negotiations.

What are the best practices when building the evidence generation strategy for a DTx product? Are you struggling with measuring meaningful clinical and economic data for your DTx? Then, this meeting is for you. Apply now to connect with peers and meet new people working in this space.

‍

There is a broad variety of digital health solutions, but in order to thrive and be successfully adopted, prescribed and reimbursed, it is essential to clinically prove their efficacy and safety. Join us in this Masterclass led by Akili Interactive to learn all about the above and hear insights from thought leaders in this space.

Are you working on virtual care solutions for COPD patients or other chronic respiratory diseases? Are you struggling with evidence generation? Then this meeting is for you! Apply now to hear insights from your peers in this space and share your own thoughts and experiences.

Join this masterclass led by Justin Norden (Partner at GSR Ventures) and Dr. Nirav R. Shah (Chief Medical Officer at Sharecare), as they walk us through 'Business Models for Digital Health Companies targeting Medicaid.' Apply now to secure your place in this exclusive Masterclass.

‍

What do you need to know to navigate the DiGa framework? Join us in this interactive masterclass led by Flying Health to learn from key thought leaders in this space. Apply now to secure your place.

‍

Join us as we discuss various topics within Virtual Care solutions in Heart Failure and other CV diseases, through the lens of evidence and outcomes. This is the perfect opportunity to meet others working in this space and share your views.

Join us for this exclusive webinar with Jeremy Sohn, Neil Tiwari and David Coman where we will deep dive into the history of DCT and the success story of Science 37. Register now to secure your place!

‍

In this session you will hear about the challenges and best practices when measuring DTx efficacy and safety and what levels of evidence the different stakeholders require. Join your fellow senior leaders to share your views and experience on this topic and meet new people in the space.

‍

Join the second meeting of this series, Led by Lee Shapiro of 7wire Ventures, as we discuss Virtual Care for T2- Diabetes and Obesity. Our sprint sessions allow you to deep dive into a particular topic and share insights with thought leaders and peers in the industry.

DTx solutions are becoming increasingly popular in the healthcare industry as they can improve patient outcomes, reduce healthcare costs and improve access to care. In this meeting, Join us as we explore how DTx companies have found their launch into the market and how they get paid through Employers and Payers, bringing examples of these partnerships. Listen, engage and enjoy!

Are you a Digital Health company, Pharma executive, Medtech executive, or Venture Capitalist (VC), working in neurology and seeking guidance to build successful partnerships? Then keep reading, this meeting is for you.

Are you working on (or planning to) bringing your Remote Patient Monitoring programs (RPM) to the APAC market? Are you finding gaps and blocks in expanding them in a sustainable way? Then this meeting is for you.  We invite you and your peers to the table for an open conversation focused on the best routes to market for RPM companies in the APAC region.

Do you work in the development and/or validation of digital measures for clinical trials? Are you struggling to include these new measures in a clinical trial? If so, Join our Digital Health Meeting to discuss all of the above in detail with senior leaders in this space.

Last month, we did a deep dive on the Employer route to market for DTx products. Join us this month as we look into other potential go-to-market strategies for Digital Therapeutics. Apply now to hear valuable insights from thought leaders in this space.

Join us as we deep dive into DTx-Pharma partnerships, with a focus on how to monetize DTx within the traditional pharmaceutical business model. Apply now to connect with peers and hear from thought leaders in this space.

‍

Join us in this US-focused Masterclass led by Clay Anselmo and Bernhard Kappe, As they walk us through the regulation of SaMD in the US. Apply now to secure your place.

‍

How can Digital Health improve cancer patients’ lives? Are you working in this industry? Keep reading, this meeting is for you. Join us as we discuss current Digital Health products in oncology and the unmet/gaps need to be addressed.

Are you struggling getting HCPs and/or patients to adopt your DTx products? Keep reading, this sprint is for you! Places are limited so apply now to join the second session of this series and discuss with other senior leaders, DTx last mile delivery.

Join our Digital Health Meeting led by Laura Gunn from Pharmstars as we discuss digital tech for Trial Recruitment and Retention. This is the perfect opportunity to connect with peers and meet new people working in this space.

Join us in this Masterclass led by Click Therapeutics, as we discuss Clinical Trials Design for Digital Health Products. Our Masterclass sessions are the perfect opportunity to hear from thought leaders in the space and share your own thoughts and experiences.

‍

Oncology treatments usually lead to adverse effects that compromise patients quality of life, hence it seems that the opportunity for DTx is particularly great in this therapeutic area. Join the meeting to discuss, How can pharma leverage DTx to improve patients’ experience with their drugs? Listen, engage and enjoy.

‍

Join our Masterclass led by Mike Pace, where we will focus on Pharmacy Benefit Managers (PBMs) as an entry point to DTx reimbursement in the US. Apply now to hear industry insights from a thought leader in this space.

‍

Join us as we discuss Digital Health for Depression & Anxiety, focusing on their clinical evidence and adoption. Apply now to hear insights from senior leaders in this space and share your own thoughts on the topic.

Join us as we discuss the question, how should RWE solutions evolve to accelerate Pharma discovery and development? This is the perfect opportunity to connect with peers and meet new people in this space.

Join this masterclass led by Redox and Orthogonal, where we will focus on the interoperability of digital health solutions in the US. Apply now to hear invaluable insights from thought leaders in the industry.

‍

In the last few years, we have seen billions invested in digital health companies - but only a handful of Unicorn exits.  Join us in this exclusive fireside chat with Bill Taranto, President at Merck Global Health Innovation Fund LLC, where we will deep dive into the Preventice Solutions story and walk you through the key learnings and challenges along his journey with them up to their $1.2b exit to Boston Scientific.

‍